Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSK | P43235 | 8/20 | 0.61 |
| ▸ | CTSL | P07711 | 3/20 | 0.61 |
| ▸ | CTSS | P25774 | 3/20 | 0.61 |
| ▸ | PPARA | Q07869 | 5/20 | 0.59 |
| ▸ | CTSB | P07858 | 2/20 | 0.55 |
| ▸ | ITGB3 | P05106 | 2/20 | 0.54 |
| ▸ | ITGA2B | P08514 | 2/20 | 0.54 |
| ▸ | PPARG | P37231 | 2/20 | 0.54 |
| ▸ | SYK | P43405 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.51 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.51 |
| ▸ | KYNU | Q16719 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL607263 | 1.00 | CTSK (0.61) | CTSKCTSLCTSSPPARACTSB | |
| SCHEMBL1410812 | 1.00 | CTSK (0.61) | CTSKCTSLCTSSPPARACTSB | |
| SCHEMBL3821264 | 0.95 | CTSK (0.62) | CTSKCTSLCTSSPPARACTSB | |
| SCHEMBL31276612 | 0.95 | CTSK (0.62) | CTSKCTSLCTSSPPARACTSB | |
| SCHEMBL3824387 | 0.91 | CTSL (0.64) | CTSKCTSLCTSSPPARACTSB | |
| SCHEMBL1409906 | 0.91 | CTSK (0.60) | CTSKCTSLCTSSPPARACTSB | |
| SCHEMBL29401640 | 0.91 | CTSK (0.63) | CTSKCTSLCTSSCTSBSYK | |
| SCHEMBL344382 | 0.91 | CTSK (0.63) | CTSKCTSLCTSSCTSBSYK | |
| SCHEMBL344381 | 0.91 | CTSK (0.63) | CTSKCTSLCTSSCTSBSYK | |
| SCHEMBL30999365 | 0.90 | CTSK (0.58) | CTSKCTSLCTSSPPARACTSB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 215 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260062378-A1 | O-TERT-BUTYL-L-SERYL-O-TERT-BUTYL-L-SERYL-GLYCINE AND PREPARATION METHOD THEREOF | SICHUAN SHIFANG SANGAO BIOCHEMICAL INDUSTRIAL CO., LTD. (CN) | 2026-03-05 | — | — | US | claimed |
| CN-119080874-A | O-tert-butyl-L-seryl-glycine and preparation method thereof | 四川什邡市三高生化实业有限公司 | 2024-12-06 | — | — | CN | claimed |
| EP-3988538-A1 | MODIFIED HYDROPHOBIC AUXILIARY MATERIAL, PREPARATION METHOD THEREFOR AND USE THEREOF | Zhejiang Zhida Pharmaceutical Co., Ltd. (CN) | 2022-04-27 | — | — | EP | claimed |
| US-20220111055-A1 | MODIFIED HYDROPHOBIC EXCIPIENT AND PREPARATION METHOD THEREOF | ZHEJIANG ZHIDA PHARMACEUTICAL CO., LTD. (CN) | 2022-04-14 | — | — | US | claimed |
| EP-4748846-A1 | METHOD FOR SYNTHESIZING AMIDE AND/OR POLYPEPTIDE BY TAKING TRANSIENTLY PROTECTED AMINO ACID AS AMMONIA COMPONENT | GUANGZHOU MEDICAL UNIVERSITY (CN) | 2026-05-27 | — | — | EP | disclosed |
| US-12616676-B2 | Preparation method and use of modified hydrophobic excipient | ZHEJIANG ZHIDA PHARMACEUTICAL CO., LTD. (CN) | 2026-05-05 | — | — | US | disclosed |
| US-20260062378-A1 | O-TERT-BUTYL-L-SERYL-O-TERT-BUTYL-L-SERYL-GLYCINE AND PREPARATION METHOD THEREOF | SICHUAN SHIFANG SANGAO BIOCHEMICAL INDUSTRIAL CO., LTD. (CN) | 2026-03-05 | — | — | US | disclosed |
| US-20260062378-A1 | O-TERT-BUTYL-L-SERYL-O-TERT-BUTYL-L-SERYL-GLYCINE AND PREPARATION METHOD THEREOF | SICHUAN SHIFANG SANGAO BIOCHEMICAL INDUSTRIAL CO., LTD. (CN) | 2026-03-05 | — | — | US | disclosed |
| US-20260008808-A1 | Method for Synthesizing Amide and/or Polypeptide Using Unprotected Amino Acid as Ammonia Component | UNIV GUANGZHOU MEDICAL (CN) | 2026-01-08 | — | — | US | disclosed |
| US-12466850-B2 | Method for producing peptide compound | NISSAN CHEMICAL CORPORATION (JP) | 2025-11-11 | — | — | US | disclosed |
| US-20250313594-A1 | TWO-RESIDUE-EXTENDED PEPTIDE AND METHOD FOR PRODUCING SAME | NATIONAL UNIVERSITY CORPORATION TOKAI NATIONAL HIGHER EDUCATION AND RESEARCH SYSTEM (JP) | 2025-10-09 | — | — | US | disclosed |
| EP-4574834-A1 | METHOD FOR SYNTHESIZING AMIDE AND/OR POLYPEPTIDE WITH UNPROTECTED AMINO ACID AS AMINE COMPONENT | GUANGZHOU MEDICAL UNIVERSITY (CN) | 2025-06-25 | — | — | EP | disclosed |
| EP-0643072-A1 | 2-Piperazinone compounds and their use | Takeda Chemical Industries, Ltd. (JP) | 1995-03-15 | — | — | EP | disclosed |
| EP-0533516-B1 | Amides of 1-(alkoxybenzyl)piperazines, processes for their preparation and pharmaceutical compositions containing them | ADIR (FR) | 1995-02-08 | — | — | EP | disclosed |
| US-5340809-A | Antihypoxic, antiischemic agents | ADIR ET COMPAGNIE (FR) | 1994-08-23 | — | — | US | disclosed |
| US-5280027-A | Quinazoline containing compound | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1994-01-18 | — | — | US | disclosed |
| US-5252558-A | Pentapeptide having specific inhibiting effect on epidermal cell proliferation, the salts thereof, pharmaceutical compositions comprising the same and a process for the preparation of the pentapeptide and the pharmaceutical compositions | RICHTER GEDEON VEGYESZETI GYAR RT (HU) | 1993-10-12 | — | — | US | disclosed |
| EP-0533516-A2 | Amides of 1-(alkoxybenzyl)piperazines, processes for their preparation and pharmaceutical compositions containing them | ADIR ET COMPAGNIE (FR) | 1993-03-24 | — | — | EP | disclosed |
| EP-0475657-A2 | Pentapeptide and salts thereof having specific inhibiting effect of epidermal cell proliferation | RICHTER GEDEON VEGYESZETI GYAR R.T. (HU) | 1992-03-18 | — | — | EP | disclosed |
| US-4518587-A | NERVOUS SYSTEM DISORDERS | S.A. PANMEDICA (FR) | 1985-05-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260008808-A1 | Method for Synthesizing Amide and/or Polypeptide Using Unprotected Amino Acid as Ammonia Component | ANPEP, PTMS, GCG | CTSK 1858/4885CTSL 67/4885CTSS 2057/4885 |
| US-12616676-B2 | Preparation method and use of modified hydrophobic excipient | CETP, LIPA, MTTP | CTSK 2251/4885CTSL 1366/4885CTSS 2330/4885 |
| US-12466850-B2 | Method for producing peptide compound | VIP, NGLY1, NPR1 | CTSK 1312/4885CTSL 450/4885CTSS 1059/4885 |
| US-20220111055-A1 | MODIFIED HYDROPHOBIC EXCIPIENT AND PREPARATION METHOD THEREOF | CETP, SLC43A1, SLC27A1 | CTSK 4188/4885CTSL 1811/4885CTSS 3839/4885 |
| US-20260062378-A1 | O-TERT-BUTYL-L-SERYL-O-TERT-BUTYL-L-SERYL-GLYCINE AND PREPARATION METHOD THEREOF | MGMT, TERT, SPTSSB | CTSK 3469/4885CTSL 1165/4885CTSS 2267/4885 |
| US-20250313594-A1 | TWO-RESIDUE-EXTENDED PEPTIDE AND METHOD FOR PRODUCING SAME | NPPA, NGLY1, ANPEP | CTSK 595/4885CTSL 190/4885CTSS 912/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.